June 7, 2013
Related News
Other posts that you should not miss.
ProAxsis Ltd today announces that the company has completed the development process for NEATstik®, a novel point-of-care …
September 4, 2017
Positive early data from the BRIDGE1 study, a three-year 1000+ patient study in bronchiectasis funded by the …
June 3, 2019
ProAxsis will be presenting further data on its ProteaseTag® technology, at the North American Cystic Fibrosis Conference, …
October 30, 2017
